Cargando…
Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates
Rift Valley fever virus (RVFV) is an important mosquito-borne veterinary and human pathogen that has caused large outbreaks of severe disease throughout Africa and the Arabian Peninsula. Currently, no licensed vaccine or therapeutics exists to treat this potentially deadly disease. The explosive nat...
Autores principales: | Smith, Darci R., Johnston, Sara C., Piper, Ashley, Botto, Miriam, Donnelly, Ginger, Shamblin, Joshua, Albariño, César G., Hensley, Lisa E., Schmaljohn, Connie, Nichol, Stuart T., Bird, Brian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962102/ https://www.ncbi.nlm.nih.gov/pubmed/29742102 http://dx.doi.org/10.1371/journal.pntd.0006474 |
Ejemplares similares
-
Aerosol Exposure to Rift Valley Fever Virus Causes Earlier and More Severe Neuropathology in the Murine Model, which Has Important Implications for Therapeutic Development
por: Reed, Christopher, et al.
Publicado: (2013) -
Perspectives of Next-Generation Live-Attenuated Rift Valley Fever Vaccines for Animal and Human Use
por: Wichgers Schreur, Paul J., et al.
Publicado: (2023) -
Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome
por: Ayers, Victoria B., et al.
Publicado: (2023) -
Alterations in the host transcriptome in vitro following Rift Valley fever virus infection
por: Pinkham, Chelsea, et al.
Publicado: (2017) -
Rift Valley Fever, Sudan, 2007 and 2010
por: Aradaib, Imadeldin E., et al.
Publicado: (2013)